Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Chronic Graft Versus Host Disease
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Lori Styles, MD
Pharmacyclics LLC.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- City of Hope Medical Center
Duarte, California, United States
- University of California, San Francisco
San Francisco, California, United States
- Stanford University
Stanford, California, United States
- Emory University, Winship Cancer Institute
Atlanta, Georgia, United States
- Dana Farber Cancer Institute
Boston, Massachusetts, United States
- University of Minnesota
Minneapolis, Minnesota, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States
- Vanderbilt University Medical Center, Henry-Joyce Cancer Clinic
Nashville, Tennessee, United States
- Fred Hutchinson Cancer Research Center
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 14 Jul 2014
- Primary completion
- 15 Sept 2017
- Completion
- 15 Sept 2017
- Last update posted
- 11 Jul 2019
- Registered enrollment
- 45
- Registry id
- NCT02195869
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.